Access cutting-edge hidradenitis suppurativa treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access hidradenitis suppurativa specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hidradenitis suppurativa treatment provided free
Hidradenitis suppurativa (HS) and atopic dermatitis (AD) are chronic inflammatory skin diseases that lead to the development of skin lesions and symptoms such as pain and discomfort. The purpose of this study is to assess molecular changes in adult participants with moderate to severe HS or with moderate to severe AD. Lutikizumab (ABT-981) is an investigational drug being developed for the treatment of HS and AD. This study will consist of 2 sub-studies: Sub-Study 1 moderate to severe hidradeni
Sponsor: AbbVie
Check if you qualify for this hidradenitis suppurativa clinical trial in Ann Arbor, MI
If you're searching for hidradenitis suppurativa treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hidradenitis suppurativa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.